ClinicalTrials.govpublic full text
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)
acellular pertussis, hepatitis b, haemophilus influenzae type b, tetanus, diphtheria, poliomyelitis
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 287390
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.